These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6184273)

  • 1. Amsacrine and 5-azacytidine in acute non lymphatic leukaemia (ANLL).
    Carella AM; Santini G; Marmont AM
    Haematologica; 1982 Oct; 67(5):811-2. PubMed ID: 6184273
    [No Abstract]   [Full Text] [Related]  

  • 2. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
    Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
    Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
    [No Abstract]   [Full Text] [Related]  

  • 3. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
    Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I
    Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.
    Arlin ZA
    Cancer Treat Rep; 1983 Nov; 67(11):967-70. PubMed ID: 6357436
    [No Abstract]   [Full Text] [Related]  

  • 5. Amsacrine with high-dose cytarabine in acute leukemia.
    Zittoun R; Bury J; Stryckmans P; Lowenberg B; Peetermans M; Rozendaal KY; Haanen C; Kerkhofs M; Jehn U; Willemze R
    Cancer Treat Rep; 1985 Dec; 69(12):1447-8. PubMed ID: 3841026
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of the treatment of recurrent acute myeloblastic leukaemia in adults (author's transl)].
    Cabanillas F
    Sangre (Barc); 1981; 26(5B):885-9. PubMed ID: 6172860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with HD-Ara C treatment in leukemia patients].
    Jehn U
    Onkologie; 1985 Feb; 8(1):37-8. PubMed ID: 3885118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of amsacrine in patients with acute leukemia at first relapse.
    Danova M; Riccardi A; Invernizzi R; Ucci G; Girino M; Montecucco CM; Cresci R; Ascari E; Mauri C
    Haematologica; 1985; 70(6):545-6. PubMed ID: 3938435
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination amsacrine and high-dose cytosine arabinoside in acute leukemia.
    Arlin ZA
    J Clin Oncol; 1985 Jan; 3(1):128. PubMed ID: 3838101
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of amsacrine, an investigational antineoplastic agent.
    Grove WR; Fortner CL; Wiernik PH
    Clin Pharm; 1982; 1(4):320-6. PubMed ID: 6764391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of amsacrine gluconate in refractory leukemia.
    Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
    Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with 5-azacytidine plus beta-2'-deoxythioguanosine in adult acute leukemia.
    Omura GA
    Cancer Treat Rep; 1977 Aug; 61(5):915-7. PubMed ID: 70273
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia.
    Zander AR; Vellekoop L; Dicke KA; Keating MJ; McCredie KB; Legha SS; Spitzer G; Verma D; Bodey GP
    Cancer Treat Rep; 1982 Nov; 66(11):1991-2. PubMed ID: 6754077
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
    Arlin ZA; Sklaroff RB; Gee TS; Kempin SJ; Howard J; Clarkson BD; Young CW
    Cancer Res; 1980 Sep; 40(9):3304-6. PubMed ID: 6933002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic reaction following administration of AMSA.
    Welt S; Dellaquila C; Arlin ZA
    Cancer Treat Rep; 1981; 65(9-10):919. PubMed ID: 6456064
    [No Abstract]   [Full Text] [Related]  

  • 18. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Vogler WR; Johnson L; Logan T; Raney M
    Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory adult acute nonlymphoblastic leukemia with subcutaneous 5-azacytidine.
    Armitage JO; Burns CP
    Cancer Treat Rep; 1977 Dec; 61(9):1721-3. PubMed ID: 74285
    [No Abstract]   [Full Text] [Related]  

  • 20. AMSA--a promising new agent in refractory acute leukemia.
    Lawrence HJ; Ries CA; Reynolds RD; Lewis JP; Koretz MM; Torti FM
    Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.